Search

Your search keyword '"Psoriatic arthritis -- Care and treatment"' showing total 17 results
Start Over Descriptor "Psoriatic arthritis -- Care and treatment" Journal biotech week
17 results on '"Psoriatic arthritis -- Care and treatment"'

1. National rheumatology and psoriasis organizations release joint guideline for psoriatic arthritis

Subjects
Psoriatic arthritis -- Care and treatment, Gastrointestinal diseases -- Care and treatment, Diabetes therapy, Evidence-based medicine, Spondylitis, Arthritis, Biotechnology, Psoriasis, Infection, Vaccination, Universities and colleges, Editors, Biotechnology industry, Pharmaceuticals and cosmetics industries, American College of Rheumatology, National Psoriasis Foundation
Abstract

2018 DEC 19 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- ATLANTA - The American College of Rheumatology (ACR) and National Psoriasis Foundation (NPF) have released [...]

Published
2018

2. Investigators from University of Oxford Release New Data on Biologics (Tapering and Discontinuation of Biologics in Patients with Psoriatic Arthritis with Low Disease Activity)

Subjects
Psoriatic arthritis -- Care and treatment, Antiarthritic agents, Psoriasis, Editors, Arthritis, Biotechnology, Biotechnology industry, Pharmaceuticals and cosmetics industries, University of Oxford
Abstract

2018 DEC 19 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- New research on Biotechnology - Biologics is the subject of a report. According to news [...]

Published
2018

3. Reports from Makati Medical Center Describe Recent Advances in Psoriatic Arthritis (Autologous Adipose-Derived Mesenchymal Stromal Cells for the Treatment of Psoriasis Vulgaris and Psoriatic Arthritis: A Case Report)

Subjects
Patient education, Medical centers, Dermatologic agents, Stem cells, Psoriatic arthritis -- Care and treatment, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2017 SEP 6 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Investigators publish new report on Autoimmune Diseases and Conditions - Psoriatic Arthritis. According to news [...]

Published
2017

4. New Psoriatic Arthritis Data Have Been Reported by Researchers at Taichung Veterans General Hospital (Depression and Insomnia in Patients With Psoriasis and Psoriatic Arthritis Taking Tumor Necrosis Factor Antagonists)

Subjects
Depression (Mood disorder) -- Care and treatment, Tumor necrosis factor, Veterans hospitals, Tumors -- Care and treatment, Medical research, Insomnia -- Care and treatment, Psoriatic arthritis -- Care and treatment, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2016 JUL 20 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Fresh data on Arthritis are presented in a new report. According to news reporting from [...]

Published
2016

5. Novartis announces NEJM publication of secukinumab Phase III data confirming significant efficacy in patients with psoriatic arthritis

Subjects
Novartis Pharmaceuticals Corp. -- Product development, Pharmaceutical industry -- Product development, Psoriatic arthritis -- Care and treatment, Biotechnology industry, Pharmaceuticals and cosmetics industries, American College of Rheumatology
Abstract

2015 OCT 14 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Novartis announced that results from the pivotal Phase III FUTURE 1 study for secukinumab in [...]

Published
2015

6. Oral OTEZLA[R] Apremilast Showed Long-Term Clinical Benefits in Patients with Active Psoriatic Arthritis

Subjects
Celgene Corp., Psoriatic arthritis -- Care and treatment, Pharmaceutical industry, Biotechnology industry, Pharmaceuticals and cosmetics industries, Otezla (Medication)
Abstract

By a News Reporter-Staff News Editor at Biotech Week -- Celgene International Sarl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), announced results of additional analyses from the phase III clinical [...]

Published
2014

7. Oral Apremilast Monotherapy Demonstrated Long-Term Clinical Benefits in Psoriatic Arthritis Patients Naive to Previous DMARD Therapy

Subjects
Celgene Corp., Psoriatic arthritis -- Care and treatment, Antirheumatic agents, Pharmaceutical industry, Biotechnology industry, Pharmaceuticals and cosmetics industries, American College of Rheumatology
Abstract

By a News Reporter-Staff News Editor at Biotech Week -- Celgene International Sarl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), announced results of its long-term phase III study on apremilast, [...]

Published
2013

8. Oral Apremilast Demonstrated Long-Term Clinical Benefits for Patients with Psoriatic Arthritis

Subjects
Celgene Corp., Psoriatic arthritis -- Care and treatment, Pharmaceutical industry, Biotechnology industry, Pharmaceuticals and cosmetics industries, American College of Rheumatology
Abstract

By a News Reporter-Staff News Editor at Biotech Week -- Celgene International Sarl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), announced results of three long-term (52-week) phase III studies [...]

Published
2013

9. New Research on Psoriatic Arthritis from University of Ioannina Summarized

Subjects
Psoriatic arthritis -- Care and treatment, Medical research, Medicine, Experimental, Antirheumatic agents, Universities and colleges, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

In this recently published article, scientists in Ioannina, Greece conducted a study 'To investigate the efficacy, toxicity, and drug discontinuation in patients with psoriatic arthritis treated with anti-tumor necrosis factor [...]

Published
2011

10. Recent Studies by B. Glintborg and Co-Authors Add New Data to Psoriatic Arthritis Findings

Subjects
Psoriatic arthritis -- Care and treatment, Antiarthritic agents, Tumor necrosis factor, Biotechnology industry, Pharmaceuticals and cosmetics industries, American College of Rheumatology
Abstract

In this recent article published in the journal Arthritis and Rheumatism, scientists in Hellerup, Denmark conducted a study 'To investigate disease activity, treatment response, and drug survival, and predictors thereof, [...]

Published
2011

11. Arthritis Foundation and National Psoriasis Foundation Launch Effort to Encourage Early Diagnosis and Treatment of Psoriatic Arthritis

Subjects
Pfizer Inc., Psoriatic arthritis -- Care and treatment, Rheumatoid factor, Pharmaceutical industry, Biotechnology industry, Pharmaceuticals and cosmetics industries, National Psoriasis Foundation, Arthritis Foundation
Abstract

Newswire/ --Two leading patient advocacy organizations have joined forces to educate people about psoriatic arthritis, an inflammatory disease that can lead to joint damage, especially if not diagnosed and treated [...]

Published
2011

12. Studies from Baylor Research Institute yield new information about psoriatic arthritis therapy

Subjects
Psoriatic arthritis -- Care and treatment, Rheumatoid factor, Dermatology -- Formulae, receipts, prescriptions, Drugs, Methotrexate, Dermatologic agents, Monoclonal antibodies, Crohn's disease -- Care and treatment, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

A new study, 'Atypical presentation of histoplasmosis in a patient with psoriasis and psoriatic arthritis on infliximab therapy,' is now available. According to recent research from the United States, 'Infliximab [...]

Published
2010

13. Data from I. Olivieri et al provide new insights into psoriatic arthritis quality of care

Subjects
Drugs -- Reports, Psoriatic arthritis -- Care and treatment, Psoriatic arthritis -- Reports, Antiarthritic agents -- Reports, Medical care -- Quality management, Medical care -- Reports, Patients -- Care and treatment, Patients -- Reports, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

A new study, 'Psoriatic arthritis: pharmacoeconomic considerations,' is now available. According to a study from Potenza, Italy, 'Tumor necrosis factor (TNF) antagonists provide a clinically and economically efficient treatment option [...]

Published
2009

14. Research from Brigham and Women's Hospital broadens understanding of psoriatic arthritis

Subjects
Psoriatic arthritis -- Care and treatment, Dermatology -- Formulae, receipts, prescriptions, Drugs, Dermatologic agents, Antiarthritic agents, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

'Psoriatic arthritis (PsA) is a chronic inflammatory joint disease associated with psoriasis. Arthritis mutilans is a rare clinical form of PsA in which osteolysis and destructive changes in the joints [...]

Published
2009

15. Studies from K. Darabi et al provide new data on psoriatic arthritis

Subjects
Psoriatic arthritis -- Care and treatment, Drugs, Methotrexate, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

'Treatment of patients with moderate-severe psoriasis and/or psoriatic arthritis includes systemic biologic, antimetabolite, and immunosuppressive therapy. However, adverse events such as serious infectious complications must be considered before starting therapy [...]

Published
2009

16. Investigators at University of Palermo, Department of Dermatology have published new data on psoriatic arthritis therapy

Subjects
Drugs -- Reports, Antiarthritic agents -- Reports, Psoriatic arthritis -- Care and treatment, Psoriatic arthritis -- Reports, Dermatologic agents -- Reports, Monoclonal antibodies -- Reports, Universities and colleges -- Reports, Dermatology -- Formulae, receipts, prescriptions, Dermatology -- Reports, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

Data detailed in 'Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis' have been presented. 'Psoriasis and psoriatic arthritis are common diseases associated with considerable morbidity and disability. [...]

Published
2009

17. New psoriatic arthritis research from R. Cuchacovich and colleagues discussed

Subjects
Rheumatoid arthritis -- Research, Rheumatoid arthritis -- Care and treatment, Psoriatic arthritis -- Research, Psoriatic arthritis -- Care and treatment, Skin -- Care and treatment, Tumor necrosis factor, Medical research, Medicine, Experimental, Rheumatoid factor, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

According to recent research from the United States, 'We report 3 patients with psoriatic arthritis and 2 with rheumatoid arthritis who developed worsening, and/or de novo psoriasis, and/or psoriasiform rash, [...]

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results